공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 동물용 백신 시장 : 제품별, 동물 유형별 예측(-2025년) - COVID-19의 누적 영향

Animal Vaccines Market Research Report by Product, by Animal Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2021년 06월 상품 코드 1002738
페이지 정보 영문 194 Pages
가격
US $ 3,949 ₩ 4,523,000 Online Access (Single User License - 1 Year)
US $ 4,949 ₩ 5,669,000 PDF (Single User License) + Excel
US $ 5,949 ₩ 6,814,000 PDF (1-5 User License) + Excel
US $ 7,949 ₩ 9,105,000 PDF (Site License) + Excel
US $ 9,949 ₩ 11,396,000 PDF (Enterprise License) + Excel


세계의 동물용 백신 시장 : 제품별, 동물 유형별 예측(-2025년) - COVID-19의 누적 영향 Animal Vaccines Market Research Report by Product, by Animal Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
발행일 : 2021년 06월 페이지 정보 : 영문 194 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 동물용 백신 시장 규모는 2020년 129억 8,256만 달러에서 2025년 말까지 185억 3,357만 달러로 확대될 것으로 예상됩니다.

COVID-19는 미증유의 세계적인 공중위생상 긴급사태이며, 모든 업계에 영향을 미쳐 왔습니다. 이 장기적 영향은 예측기간 중 업계의 성장에 영향을 미칠 것으로 예측됩니다. 우리가 진행하고 있는 조사에서는 기저에 있는 COVID-19의 문제와 향후 방향을 확실히 다루기 위해 조사 범위를 확대시키고 있습니다. 소비자의 행동과 수요 변화, 구입 패턴, 공급망 재설정, 현재 시장 동향 및 정부의 중요한 개입 등을 고려하면서, COVID-19에 대한 인사이트를 제공합니다. 업데이트된 조사에서는 COVID-19가 시장에 미치는 영향을 고려하고, 인사이트, 분석, 예측 등을 제공합니다.

세계의 동물용 백신(Animal Vaccines) 시장에 대해 조사했으며, 시장 기회와 과제, 성장 촉진요인 및 억제요인, COVID-19의 누적 영향, 제품·동물 유형·지역별 시장 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 서문

  • 조사 목적
  • 시장 세분화와 커버리지
  • 조사 기간
  • 통화와 가격
  • 언어
  • 제한 사항
  • 이해관계자

제2장 조사 방법

  • 조사 프로세스
    • 정의 : 조사 목적
    • 결정 : 조사 설계
    • 준비 : 조사 툴
    • 수집 : 데이터 소스
    • 분석 : 데이터 분석
    • 책정 : 데이터 검증
    • 공개 : 조사 보고서
    • 반복 : 보고서 업데이트
  • 조사 시행
    • 개시 : 조사 프로세스
    • 계획 : 조사 계획 작성
    • 시행 : 조사 시행
    • 검증 : 발견 및 분석
    • 출판물 : 조사 보고
  • 조사 성과

제3장 개요

  • 시장 전망
  • 동물 유형별 시장 전망
  • 제품별 시장 전망
  • 지역별 시장 전망
  • 경쟁사 전망

제4장 시장 개요

  • COVID-19의 누적 영향

제5장 시장 인사이트

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제
  • Porter's Five Forces 분석

제6장 세계의 동물용 백신 시장, 제품별

  • 약독 생백신
  • DNA 백신
  • 불활화 백신
  • 재조합 백신
  • 아단위 백신

제7장 동물 유형별 시장

  • 수산양식
    • 아에로모나스
    • 연쇄상구균 감염증
    • 비브리오
  • 반려동물
    • 고양이
  • 가금류
    • 조류인 플루엔자
    • 전염성 기관지염
    • 마렉병
    • 뉴캐슬병
    • 살모네라
  • 반추동물
    • 코로나바이러스
    • 대장균
    • 구제역(FMD)
    • 럼피스킨병
    • 로타바이러스

제8장 아메리카 시장

  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

제9장 아시아태평양 시장

  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 한국
  • 태국

제10장 유럽, 중동 및 아프리카 시장

  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트(UAE)
  • 영국

제11장 경쟁 구도

  • FPNV 포지셔닝 매트릭스
    • Quadrants
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 시장 점유율 분석
  • 경쟁사의 SWOT 분석
  • 경쟁 시나리오
    • 인수합병(M&A)
    • 계약/협업/제휴
    • 신제품 발매와 강화
    • 투자 및 펀딩
    • 수상/인지/확대

제12장 기업 개요

  • Anicon Labor GmbH
  • Biogenesis Bago S.A.
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private Limited
  • CEVA Inc
  • China Animal Husbandry Industry Co., Ltd.
  • Elanco LLC
  • Endovac Animal Health, LLC
  • Heska Corporation
  • Hester Biosciences Limited
  • HIPRA SA
  • Indian Immunologicals Limited
  • Jinyu Bio-Technology Co., Ltd.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Phibro Animal Health Corporation
  • Sanofi S.A.
  • Torigen Pharmaceuticals Inc
  • Vaxxinova GmbH
  • VEROVACCiNES GmbH
  • Vetoquinol SA
  • Virbac, Inc.
  • Zoetis Inc.

제13장 부록

  • 디스커션 가이드
  • 라이선스와 가격
LSH 21.05.14

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL VACCINES MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2020 (USD BILLION)
  • FIGURE 3. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2020 (USD BILLION)
  • FIGURE 4. GLOBAL ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL ANIMAL VACCINES MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL ANIMAL VACCINES MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2020 VS 2026 (USD BILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2026
  • FIGURE 10. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, 2018-2026 (USD BILLION)
  • FIGURE 11. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 12. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DNA VACCINES, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DNA VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2026 (USD BILLION)
  • FIGURE 17. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, 2018-2026 (USD BILLION)
  • FIGURE 19. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 20. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2020 VS 2026 (%)
  • FIGURE 21. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2020 VS 2026 (USD BILLION)
  • FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2026
  • FIGURE 23. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2026 (USD BILLION)
  • FIGURE 24. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AQUA, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 25. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AEROMONAS, 2018-2026 (USD BILLION)
  • FIGURE 26. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AEROMONAS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 27. GLOBAL ANIMAL VACCINES MARKET SIZE, BY STREPTOCOCCOSIS, 2018-2026 (USD BILLION)
  • FIGURE 28. GLOBAL ANIMAL VACCINES MARKET SIZE, BY STREPTOCOCCOSIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 29. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VIBRIO, 2018-2026 (USD BILLION)
  • FIGURE 30. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VIBRIO, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 31. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2026 (USD BILLION)
  • FIGURE 32. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 33. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2026 (USD BILLION)
  • FIGURE 34. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 35. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE HERPES, 2018-2026 (USD BILLION)
  • FIGURE 36. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE HERPES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 37. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTEMPER, 2018-2026 (USD BILLION)
  • FIGURE 38. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTEMPER, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 39. GLOBAL ANIMAL VACCINES MARKET SIZE, BY KENNEL COUGH, 2018-2026 (USD BILLION)
  • FIGURE 40. GLOBAL ANIMAL VACCINES MARKET SIZE, BY KENNEL COUGH, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 41. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LYME DISEASE, 2018-2026 (USD BILLION)
  • FIGURE 42. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LYME DISEASE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 43. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PARVOVIRUS, 2018-2026 (USD BILLION)
  • FIGURE 44. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PARVOVIRUS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 45. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES, 2018-2026 (USD BILLION)
  • FIGURE 46. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 47. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2026 (USD BILLION)
  • FIGURE 48. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FELINE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 49. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CALICIVIRUS, 2018-2026 (USD BILLION)
  • FIGURE 50. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CALICIVIRUS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 51. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS, 2018-2026 (USD BILLION)
  • FIGURE 52. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 53. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PANLEUKOPENIA, 2018-2026 (USD BILLION)
  • FIGURE 54. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PANLEUKOPENIA, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 55. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES, 2018-2026 (USD BILLION)
  • FIGURE 56. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 57. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RHINOTRACHEITIS, 2018-2026 (USD BILLION)
  • FIGURE 58. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RHINOTRACHEITIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 59. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2026 (USD BILLION)
  • FIGURE 60. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 61. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AVIAN INFLUENZA, 2018-2026 (USD BILLION)
  • FIGURE 62. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AVIAN INFLUENZA, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 63. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INFECTIOUS BRONCHITIS, 2018-2026 (USD BILLION)
  • FIGURE 64. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INFECTIOUS BRONCHITIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 65. GLOBAL ANIMAL VACCINES MARKET SIZE, BY MAREK'S DISEASE, 2018-2026 (USD BILLION)
  • FIGURE 66. GLOBAL ANIMAL VACCINES MARKET SIZE, BY MAREK'S DISEASE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 67. GLOBAL ANIMAL VACCINES MARKET SIZE, BY NEWCASTLE DISEASE, 2018-2026 (USD BILLION)
  • FIGURE 68. GLOBAL ANIMAL VACCINES MARKET SIZE, BY NEWCASTLE DISEASE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 69. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SALMONELLA, 2018-2026 (USD BILLION)
  • FIGURE 70. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SALMONELLA, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 71. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2026 (USD BILLION)
  • FIGURE 72. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 73. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS, 2018-2026 (USD BILLION)
  • FIGURE 74. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 75. GLOBAL ANIMAL VACCINES MARKET SIZE, BY E. COLI, 2018-2026 (USD BILLION)
  • FIGURE 76. GLOBAL ANIMAL VACCINES MARKET SIZE, BY E. COLI, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 77. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE (FMD), 2018-2026 (USD BILLION)
  • FIGURE 78. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE (FMD), BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 79. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LUMPY SKIN, 2018-2026 (USD BILLION)
  • FIGURE 80. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LUMPY SKIN, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 81. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROTAVIRUS, 2018-2026 (USD BILLION)
  • FIGURE 82. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROTAVIRUS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 83. AMERICAS ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 84. AMERICAS ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 85. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 86. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 87. BRAZIL ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 88. CANADA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 89. MEXICO ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 90. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 91. CALIFORNIA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 92. FLORIDA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 93. ILLINOIS ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 94. NEW YORK ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 95. OHIO ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 96. PENNSYLVANIA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 97. TEXAS ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 98. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 99. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 100. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 101. CHINA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 102. INDIA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 103. INDONESIA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 104. JAPAN ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 105. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 106. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 107. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 108. THAILAND ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 109. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 110. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 111. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 112. FRANCE ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 113. GERMANY ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 114. ITALY ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 115. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 116. QATAR ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 117. RUSSIA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 118. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 119. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 120. SPAIN ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 121. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 122. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 123. GLOBAL ANIMAL VACCINES MARKET: FPNV POSITIONING MATRIX
  • FIGURE 124. GLOBAL ANIMAL VACCINES MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 125. GLOBAL ANIMAL VACCINES MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 126. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANIMAL VACCINES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL VACCINES MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DNA VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AQUA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AEROMONAS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL ANIMAL VACCINES MARKET SIZE, BY STREPTOCOCCOSIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VIBRIO, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE HERPES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTEMPER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. GLOBAL ANIMAL VACCINES MARKET SIZE, BY KENNEL COUGH, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LYME DISEASE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PARVOVIRUS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FELINE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CALICIVIRUS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PANLEUKOPENIA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RHINOTRACHEITIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AVIAN INFLUENZA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INFECTIOUS BRONCHITIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. GLOBAL ANIMAL VACCINES MARKET SIZE, BY MAREK'S DISEASE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. GLOBAL ANIMAL VACCINES MARKET SIZE, BY NEWCASTLE DISEASE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SALMONELLA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. GLOBAL ANIMAL VACCINES MARKET SIZE, BY E. COLI, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE (FMD), BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LUMPY SKIN, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROTAVIRUS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. AMERICAS ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. AMERICAS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. AMERICAS ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. BRAZIL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. BRAZIL ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. CANADA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. CANADA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. MEXICO ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. MEXICO ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. CALIFORNIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. CALIFORNIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. FLORIDA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. FLORIDA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. ILLINOIS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. ILLINOIS ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. NEW YORK ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. NEW YORK ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. OHIO ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. OHIO ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. PENNSYLVANIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. PENNSYLVANIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. TEXAS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. TEXAS ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. CHINA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. CHINA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. INDIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. INDIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. INDONESIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. INDONESIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. JAPAN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. JAPAN ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. THAILAND ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. THAILAND ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 90. FRANCE ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 91. FRANCE ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 92. GERMANY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 93. GERMANY ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 94. ITALY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 95. ITALY ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 96. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 97. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 98. QATAR ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 99. QATAR ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 100. RUSSIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 101. RUSSIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 102. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 103. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 104. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 105. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 106. SPAIN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 107. SPAIN ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 108. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 109. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 110. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 111. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 112. GLOBAL ANIMAL VACCINES MARKET: SCORES
  • TABLE 113. GLOBAL ANIMAL VACCINES MARKET: BUSINESS STRATEGY
  • TABLE 114. GLOBAL ANIMAL VACCINES MARKET: PRODUCT SATISFACTION
  • TABLE 115. GLOBAL ANIMAL VACCINES MARKET: RANKING
  • TABLE 116. GLOBAL ANIMAL VACCINES MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 117. GLOBAL ANIMAL VACCINES MARKET: SHARE, BY COMPANY, 2020
  • TABLE 118. GLOBAL ANIMAL VACCINES MARKET: MERGER & ACQUISITION
  • TABLE 119. GLOBAL ANIMAL VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 120. GLOBAL ANIMAL VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 121. GLOBAL ANIMAL VACCINES MARKET: INVESTMENT & FUNDING
  • TABLE 122. GLOBAL ANIMAL VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 123. GLOBAL ANIMAL VACCINES MARKET: LICENSE & PRICING
  • TABLE 124. GLOBAL ANIMAL VACCINES MARKET: CONTACT DETAILS

The Global Animal Vaccines Market size was estimated at USD 12.98 Billion in 2020 and expected to reach USD 14.00 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 8.21% to reach USD 20.85 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Animal Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product , the Animal Vaccines Market was studied across Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Subunit Vaccines.

Based on Animal Type , the Animal Vaccines Market was studied across Aqua, Companion, Poultry, and Ruminants. The Aqua is further studied across Aeromonas, Streptococcosis, and Vibrio. The Companion is further studied across Canine and Feline. The Poultry is further studied across Avian Influenza, Infectious Bronchitis, Marek's Disease, Newcastle Disease, and Salmonella. The Ruminants is further studied across Coronavirus, E. Coli, Foot & mouth disease (FMD), Lumpy skin, and Rotavirus.

Based on Geography, the Animal Vaccines Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Vaccines Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Animal Vaccines Market, including Anicon Labor GmbH, Biogenesis Bago S.A., Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, CEVA Inc, China Animal Husbandry Industry Co., Ltd., Elanco LLC, Endovac Animal Health, LLC, Heska Corporation, Hester Biosciences Limited, HIPRA SA, Indian Immunologicals Limited, Jinyu Bio-Technology Co., Ltd., Merck & Co., Inc., Neogen Corporation, Phibro Animal Health Corporation, Phibro Animal Health Corporation, Sanofi S.A., Torigen Pharmaceuticals Inc, Vaxxinova GmbH, VEROVACCiNES GmbH, Vetoquinol SA, Virbac, Inc., and Zoetis Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Animal Vaccines Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Animal Vaccines Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Animal Vaccines Market?
  • 4. What is the competitive strategic window for opportunities in the Global Animal Vaccines Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Animal Vaccines Market?
  • 6. What is the market share of the leading vendors in the Global Animal Vaccines Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Animal Vaccines Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Animal Type Outlook
  • 3.4. Product Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing livestock population
      • 5.1.1.2. Rising animal husbandry along with commercialization of animal products
      • 5.1.1.3. Increasing incidences of zoonotic diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High Storage cost of vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Shift from live attenuated vaccines to DNA vaccines
      • 5.1.3.2. Continuous technology advancements in vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse impacts of vaccines
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Animal Vaccines Market, by Product

  • 6.1. Introduction
  • 6.2. Attenuated Live Vaccines
  • 6.3. DNA Vaccines
  • 6.4. Inactivated Vaccines
  • 6.5. Recombinant Vaccines
  • 6.6. Subunit Vaccines

7. Animal Vaccines Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Aqua
    • 7.2.1. Aeromonas
    • 7.2.2. Streptococcosis
    • 7.2.3. Vibrio
  • 7.3. Companion
    • 7.3.1. Canine
      • 7.3.1.1. Canine Herpes
      • 7.3.1.2. Distemper
      • 7.3.1.3. Kennel Cough
      • 7.3.1.4. Lyme Disease
      • 7.3.1.5. Parvovirus
      • 7.3.1.6. Rabies
    • 7.3.2. Feline
      • 7.3.2.1. Calicivirus
      • 7.3.2.2. Coronavirus
      • 7.3.2.3. Panleukopenia
      • 7.3.2.4. Rabies
      • 7.3.2.5. Rhinotracheitis
  • 7.4. Poultry
    • 7.4.1. Avian Influenza
    • 7.4.2. Infectious Bronchitis
    • 7.4.3. Marek's Disease
    • 7.4.4. Newcastle Disease
    • 7.4.5. Salmonella
  • 7.5. Ruminants
    • 7.5.1. Coronavirus
    • 7.5.2. E. Coli
    • 7.5.3. Foot & mouth disease (FMD)
    • 7.5.4. Lumpy skin
    • 7.5.5. Rotavirus

8. Americas Animal Vaccines Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Animal Vaccines Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Animal Vaccines Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Anicon Labor GmbH
  • 12.2. Biogenesis Bago S.A.
  • 12.3. Boehringer Ingelheim International GmbH
  • 12.4. Brilliant Bio Pharma Private Limited
  • 12.5. CEVA Inc
  • 12.6. China Animal Husbandry Industry Co., Ltd.
  • 12.7. Elanco LLC
  • 12.8. Endovac Animal Health, LLC
  • 12.9. Heska Corporation
  • 12.10. Hester Biosciences Limited
  • 12.11. HIPRA SA
  • 12.12. Indian Immunologicals Limited
  • 12.13. Jinyu Bio-Technology Co., Ltd.
  • 12.14. Merck & Co., Inc.
  • 12.15. Neogen Corporation
  • 12.16. Phibro Animal Health Corporation
  • 12.17. Phibro Animal Health Corporation
  • 12.18. Sanofi S.A.
  • 12.19. Torigen Pharmaceuticals Inc
  • 12.20. Vaxxinova GmbH
  • 12.21. VEROVACCiNES GmbH
  • 12.22. Vetoquinol SA
  • 12.23. Virbac, Inc.
  • 12.24. Zoetis Inc.

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details
Back to Top
전화 문의
F A Q